Skip to content
Friday, March 31, 2023
Latest:
  • Tepezza Lawsuit
  • The key factors that could contribute to the emergence of a new pandemic virus
  • FDA recalls Quinapril linked to Cancer
  • Paraquat Lawsuit
  • Lung Cancer is a leading cause of death worldwide

Faulty Drugs

Faulty Pharmaceutical Drugs Resources

  • Home
  • FDA Recalls
  • Drug Recalls
  • Current Lawsuits
  • Contact

Novartis

Drug Recalls FDA Advisory Valsartan 

Valsartan recalled for cancer link

July 7, 2018July 7, 2018 film-coated tablets, HCT, N-Nitrosodimethylamine, NDMA, Novartis, Sandoz valsartan

The heart drug valsartan is being recalled in 22 countries. It contains a chemical that poses a potential cancer risk.

Read more
FDA Advisory 

Blood pressure medications linked to increased risk of cancer

June 12, 2010June 14, 2010 Amias, angiotensin-receptor, Aprovel, ARB, Atacand, Avapro, Benicar, Blood pressure, Blopress, Candesartan, Cozaar, Diovan, Irbesartan, Karvea, Losartan, Micardis, Novartis, Olmesartan, Olmetec, Ratacand, Telmisartan, Valsartan

According to a study published in the British medical journal The Lancet Oncology, certain blood pressure medications may be linked to

Read more

Recent Posts

  • Tepezza Lawsuit
  • The key factors that could contribute to the emergence of a new pandemic virus
  • FDA recalls Quinapril linked to Cancer
  • Paraquat Lawsuit
  • Lung Cancer is a leading cause of death worldwide

Categories

Useful Links

  • DailyMed – marketed drugs
  • FDA Drug Recalls
  • MedlinePlus Drugs Information
  • Pillbox – Pill identification
Copyright © 2023 Faulty Drugs. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.